Transfer of Shares and Director PDMR Shareholding

Diaceutics PLC

(“Diaceutics” or the “Company”)

Transfer of Shares and Director/PDMR Shareholding

Diaceutics PLC (AIM: DXRX), the diagnostic commercialisation company, has today been informed that Philip White has made the following transfers of a total of 1,119,941 ordinary shares of £0.002 each in the Company (“Ordinary Shares”) to his former spouse as detailed below.

On 6th April 2021, Philip White transferred 615,041 Ordinary Shares in the Company held in his own name and 504,900 Ordinary Shares in the Company held in his SIPP (the Philip White Tyres Pension Trust 81810) to Jemma White and The Xafinity SIPP re Jemma White, respectively, both for nil consideration.

As a result of this transfer, the beneficial holding of Philip White and his connected parties in the Company is 1,906,389 Ordinary Shares, representing 2.27% of the Company's issued share capital.

Enquiries

Diaceutics PLC

Peter Keeling, Chief Executive Officer

Philip White, Chief Financial Officer

 
Cenkos Securities plc (Nominated adviser and broker)

Callum Davidson / Giles Balleny

Michael Johnson (Sales)

+44 (0)207 397 8900

Walbrook PR

Anna Dunphy

Mob: +44 (0)7876 741 001

Paul McManus

Mob: +44 (0)7980 541 893